Triple hormone-receptor assay: a more accurate predictive tool for the treatment of advanced breast cancer?
In a group of 74 patients with advanced metastatic breast cancer, 57% of those with cytoplasmic oestrogen receptor activity in their tumours (REC+) showed a clinical response to endocrine therapy. Of 51 patients whose tumour was assayed for both REC and cytoplasmic progesterone (RPC) activity, 9/12...
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
1979
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010127/ |